Outpatient pharmaceutical office: access to medicines in public health
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/210971 |
Resumo: | We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System - SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines - RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT. |
id |
USP-31_18a397e406bb7754b8f662f292da4a35 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/210971 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Outpatient pharmaceutical office: access to medicines in public healthAccess to essential medicines; Pharmaceutical care; Ambulatory care; Health policy; Unified health systemWe evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System - SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines - RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-04-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21097110.1590/s2175-97902023e21244Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21244 COPYBrazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21244 COPYBrazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21244 COPY2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/210971/194560https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessBelmiro Morgado JuniorCésar Augusto Abreu-PereiraMaria Amelia Zanon PonceRosana De Gasperi PagliusoAdriana Melo Jorge SantosAdriane Lopes Medeiros Simone2023-05-29T20:03:30Zoai:revistas.usp.br:article/210971Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-29T20:03:30Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Outpatient pharmaceutical office: access to medicines in public health |
title |
Outpatient pharmaceutical office: access to medicines in public health |
spellingShingle |
Outpatient pharmaceutical office: access to medicines in public health Belmiro Morgado Junior Access to essential medicines; Pharmaceutical care; Ambulatory care; Health policy; Unified health system |
title_short |
Outpatient pharmaceutical office: access to medicines in public health |
title_full |
Outpatient pharmaceutical office: access to medicines in public health |
title_fullStr |
Outpatient pharmaceutical office: access to medicines in public health |
title_full_unstemmed |
Outpatient pharmaceutical office: access to medicines in public health |
title_sort |
Outpatient pharmaceutical office: access to medicines in public health |
author |
Belmiro Morgado Junior |
author_facet |
Belmiro Morgado Junior César Augusto Abreu-Pereira Maria Amelia Zanon Ponce Rosana De Gasperi Pagliuso Adriana Melo Jorge Santos Adriane Lopes Medeiros Simone |
author_role |
author |
author2 |
César Augusto Abreu-Pereira Maria Amelia Zanon Ponce Rosana De Gasperi Pagliuso Adriana Melo Jorge Santos Adriane Lopes Medeiros Simone |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Belmiro Morgado Junior César Augusto Abreu-Pereira Maria Amelia Zanon Ponce Rosana De Gasperi Pagliuso Adriana Melo Jorge Santos Adriane Lopes Medeiros Simone |
dc.subject.por.fl_str_mv |
Access to essential medicines; Pharmaceutical care; Ambulatory care; Health policy; Unified health system |
topic |
Access to essential medicines; Pharmaceutical care; Ambulatory care; Health policy; Unified health system |
description |
We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System - SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines - RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient’s diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-04-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/210971 10.1590/s2175-97902023e21244 |
url |
https://www.revistas.usp.br/bjps/article/view/210971 |
identifier_str_mv |
10.1590/s2175-97902023e21244 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/210971/194560 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21244 COPY Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21244 COPY Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21244 COPY 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222918009946112 |